A Study of Chimeric Antigen Receptor T Cells Combined With Interventional Therapy in Advanced Liver Malignancy
Status:
Unknown status
Trial end date:
2018-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect the date on the safety and potential effectiveness of
CART cells combined with interventional therapy in patients with advanced liver malignancy.